Skip to main content
lexblog.com/lib/RS099Z08viewrecordjson
LEX-WK-RS099Z08crawled 2021-11-08 10:14Z

FDA Issues New Guidance on Biosimilar Development under the BPCIA

Caitlin M. Wilmot · Biosimilars Law Bulletin · Published January 11, 2019

Work details

firm or organization
Rothwell Figg
published
2019-01-11

Citation

Caitlin M. Wilmot, FDA Issues New Guidance on Biosimilar Development under the BPCIA, Biosimilars Law Bulletin (January 11, 2019) [The Library at LexBlog, LEX-WK-RS099Z08, lexpid.org/RS099Z08]